Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration

NCT: NCT03348995 · ACTIVE_NOT_RECRUITING

NCT IDNCT03348995
StatusACTIVE_NOT_RECRUITING
Start Date2018-04-17
Completion2034-04-17
SponsorMiach Orthopaedics (INDUSTRY)
First posted
Last updated

Brief Summary

Bridge-Enhanced ACL Restoration (BEAR) is a new procedure being developed to treat patients with ACL injuries. In the BEAR procedure, an implant is placed between the torn ends of the ACL and the patient's own blood is added to the implant to stimulate ligament healing. We propose the current study to determine if older patients do better than younger patients (or vice versa) with this procedure. This is a cohort study designed to determine if age is a risk factor for a worse outcome after a bridge-enhanced ACL repair (BEAR) as defined by an 11.5 point difference on the IKDC Subjective or Objective Knee Evaluation score at two years after surgery. Additional objectives are to determine the effect of age on safety outcomes including infection, graft rejection, and need for further surgical procedures.

Frequently Asked Questions

What is The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration?

The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration is a clinical trial registered under NCT03348995. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03348995?

The current status of NCT03348995 (The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration) is: ACTIVE_NOT_RECRUITING.

When did The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration start?

The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration started on 2018-04-17.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.